Literature DB >> 25410217

Diabetic neuropathy and foot complications.

Andrew J M Boulton1.   

Abstract

Foot ulceration and Charcot neuroarthropathy (CN) are well recognized and documented late sequelae of diabetic peripheral, somatic, and sympathetic autonomic neuropathy. The neuropathic foot, however, does not ulcerate spontaneously: it is a combination of loss of sensation due to neuropathy together with other factors such as foot deformity and external trauma that results in ulceration and indeed CN. The commonest trauma leading to foot ulcers in the neuropathic foot in Western countries is from inappropriate footwear. Much of the management of the insensate foot in diabetes has been learned from leprosy which similarly gives rise to insensitive foot ulceration. No expensive equipment is required to identify the high risk foot and recently developed tests such as the Ipswich Touch Test and the Vibratip have been shown to be useful in identifying the high risk foot. A comprehensive screening program, together with education of high risk patients, should help to reduce the all too high incidence of ulceration in diabetes. More recently another very high risk group has been identified, namely patients on dialysis, who are at extremely high risk of developing foot ulceration; this should be preventable. The most important feature in management of neuropathic foot ulceration is offloading as patients can easily walk on active foot ulcers due to the loss of pain sensation. Infection should be treated aggressively and if there is any evidence of peripheral vascular disease, arteriography and appropriate surgical management is also indicated. CN often presents with a unilateral hot, swollen foot and any patient presenting with these features known to have neuropathy should be treated as a Charcot until this is proven otherwise. Most important in the management of acute CN is offloading, often in a total contact cast.

Entities:  

Keywords:  Charcot neuroarthropathy; Diabetic neuropathy; foot ulceration; screening

Mesh:

Year:  2014        PMID: 25410217     DOI: 10.1016/B978-0-444-53480-4.00008-4

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  19 in total

1.  [Neuropathy and diabetic foot ulcers].

Authors:  R Lobmann
Journal:  Internist (Berl)       Date:  2015-05       Impact factor: 0.743

2.  A randomized controlled trial comparing helium-neon laser therapy and infrared laser therapy in patients with diabetic foot ulcer.

Authors:  Sayed A Tantawy; Walid K Abdelbasset; Dalia M Kamel; Saud M Alrawaili
Journal:  Lasers Med Sci       Date:  2018-05-30       Impact factor: 3.161

3.  Peripheral Neuropathy and All-Cause and Cardiovascular Mortality in U.S. Adults : A Prospective Cohort Study.

Authors:  Caitlin W Hicks; Dan Wang; Kunihiro Matsushita; B Gwen Windham; Elizabeth Selvin
Journal:  Ann Intern Med       Date:  2020-12-08       Impact factor: 25.391

Review 4.  Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes.

Authors:  Caitlin W Hicks; Elizabeth Selvin
Journal:  Curr Diab Rep       Date:  2019-08-27       Impact factor: 4.810

5.  Transcultural adaptation and validation of Italian Selfcare diabetic foot questionnaire.

Authors:  Emmanuel Navarro-Flores; Carlos Romero-Morales; Jorge Hugo Villafañe; Ricardo Becerro-de-Bengoa-Vallejo; Daniel López-López; Marta Elena Losa-Iglesias; César Calvo-Lobo; Patricia Palomo-López
Journal:  Int Wound J       Date:  2021-05-03       Impact factor: 3.315

Review 6.  Signal transduction mechanism of exosomes in diabetic complications (Review).

Authors:  Xueting Li; Shuo Shi; Dehuai Jing; Xinjian Li; Bin Zhang; Qingli Bie
Journal:  Exp Ther Med       Date:  2021-12-17       Impact factor: 2.447

Review 7.  Neuropathy and Diabetic Foot Syndrome.

Authors:  Maren Volmer-Thole; Ralf Lobmann
Journal:  Int J Mol Sci       Date:  2016-06-10       Impact factor: 5.923

8.  Markers of Local Inflammation and Bone Resorption in the Acute Diabetic Charcot Foot.

Authors:  Rasmus Bo Jansen; Tomas Møller Christensen; Jens Bülow; Lene Rørdam; Niklas Rye Jørgensen; Ole Lander Svendsen
Journal:  J Diabetes Res       Date:  2018-08-02       Impact factor: 4.011

9.  Foot function and strength of patients with diabetes grouped by ulcer risk classification (IWGDF).

Authors:  Jane S S P Ferreira; João P Panighel; Érica Q Silva; Renan L Monteiro; Ronaldo H Cruvinel Júnior; Isabel C N Sacco
Journal:  Diabetol Metab Syndr       Date:  2019-10-30       Impact factor: 3.320

10.  Vaccarin Regulates Diabetic Chronic Wound Healing through FOXP2/AGGF1 Pathways.

Authors:  Yixiao Liu; Jiangnan Sun; Xinyu Ma; Shuangshuang Li; Min Ai; Fei Xu; Liying Qiu
Journal:  Int J Mol Sci       Date:  2020-03-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.